4//SEC Filing
TREACE JAMES T 4
Accession 0001209191-23-015075
CIK 0001630627other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:00 PM ET
Size
7.9 KB
Accession
0001209191-23-015075
Insider Transaction Report
Form 4
TREACE JAMES T
Director
Transactions
- Sale
Common Stock
2023-02-28$21.54/sh−37,316$803,787→ 974,125 total - Sale
Common Stock
2023-03-01$21.36/sh−12,684$270,930→ 961,441 total
Holdings
- 556,183(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4100 to $22.2250 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.9700 to $21.5200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001185191
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:00 PM ET
- Size
- 7.9 KB